Dr Malini Rajagopalan
Malini Rajagopalan, PhD, is Vice President and Head of Marketing at 1Cell.Ai, where she leads strategic marketing, product positioning and customer engagement for AI-driven single-cell multi-omics technologies in oncology. With over 20 years of experience in the oncology space, she has led global initiatives across diagnostics, medical devices and life sciences, bringing innovative products to market and guiding cross-functional teams from development through commercialisation.
She holds a PhD in Molecular Biophysics from the Indian Institute of Science and has held senior roles at companies including ChromaCode, Agendia and Millennium Health. Passionate about bridging science and strategy, Malini focuses on translating complex molecular insights into impactful clinical solutions that support precision cancer care.
ArticleFrom data to therapy: emerging tech driving cancer drug discovery
Multiomics, AI and liquid biopsies are giving researchers real-time insight into tumour biology and enabling more personalised cancer therapies. Find out how these technologies are advancing biomarker discovery, improving patient stratification, and guiding the design of new treatments.